Post-Grant Review Of Small Interfering RNA Molecule Patent Sought
ALEXANDRIA, Va. — In an April 2 petition for post-grant review (PGR) filed with the Patent Trial and Appeal Board, a pharmaceutical company warns that allowing small interfering ribonucleic acid (siRNA)...To view the full article, register now.
Already a subscriber? Click here to view full article